Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362689449> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4362689449 endingPage "36" @default.
- W4362689449 startingPage "36" @default.
- W4362689449 abstract "Background: Cardiovascular disease, one of the most common types of disease in clinical practice today, carries a very high risk of disability and death. This research aims to examine genome-wide changes in injured human dermal microvascular endothelial cells (HDMECs) using the Ribonucleic Acid sequencing (RNA-Seq) technique, and to search for key genes influencing N6-methyladenosine (m6A) methylation, thus gaining new insights into future clinical diagnosis and treatment of cardiovascular diseases (CVDs) and laying a foundation for follow-up research. Methods: Impaired HDMECs (injury group), established by endotoxin intervention, were analyzed by RNA-Seq for differentially expressed genes (DEGs) relative to normal HDMECs (control group). Then, DEGs that might be associated with m6A methylation were selected for expression blocking to observe m6A methylation alterations. The migration, angiogenesis, and inflammatory response of damaged HDMECs were detected by cell scratch assay, western blotting, and Enzyme-linked Immunosorbent Assay (ELISA) experiments, respectively. Results: In this study, 20 DEGs were screened out from the two groups by RNA-Seq, of which 17 were up-regulated and 3 were down-regulated. The C-C motif chemokine receptor 10 (<i>CCR10</i>) was selected for subsequent analysis. Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) identified elevated <i>CCR10</i> expression and reduced m6A methylation levels in the injury group (<i>p</i> < 0.05). After blocking <i>CCR10</i> expression in damaged HDMECs by BI6901 (a <i>CCR10</i> specific blocker) m6A methylation, cell activity, vascular endothelial growth factor A (VEGFA) and CD31 protein expression, as well as relative length and branches of tube formation were found to be increased compared with the injury group, while the levels of inflammatory factors interleukin-1 (IL-1), interleukin-1 (IL-6) and tumor necrosis factor-α (TNF-α) were decreased (<i>p</i> < 0.05). Conclusions: Blocking <i>CCR10</i> expression can activate m6A methylation, promote cell activity, inhibit inflammatory reactions and alleviate HDMEC injury, which may become a breakthrough in future diagnosis and treatment of cardiovascular diseases." @default.
- W4362689449 created "2023-04-08" @default.
- W4362689449 creator A5042494183 @default.
- W4362689449 creator A5051959906 @default.
- W4362689449 creator A5082391340 @default.
- W4362689449 creator A5089440106 @default.
- W4362689449 date "2023-01-01" @default.
- W4362689449 modified "2023-09-29" @default.
- W4362689449 title "Blocking <i>CCR10</i> Expression Activates m6A Methylation and Alleviates Vascular Endothelial Cell Injury" @default.
- W4362689449 doi "https://doi.org/10.24976/discov.med.202335174.5" @default.
- W4362689449 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37024440" @default.
- W4362689449 hasPublicationYear "2023" @default.
- W4362689449 type Work @default.
- W4362689449 citedByCount "0" @default.
- W4362689449 crossrefType "journal-article" @default.
- W4362689449 hasAuthorship W4362689449A5042494183 @default.
- W4362689449 hasAuthorship W4362689449A5051959906 @default.
- W4362689449 hasAuthorship W4362689449A5082391340 @default.
- W4362689449 hasAuthorship W4362689449A5089440106 @default.
- W4362689449 hasBestOaLocation W43626894491 @default.
- W4362689449 hasConcept C104317684 @default.
- W4362689449 hasConcept C12823836 @default.
- W4362689449 hasConcept C13373296 @default.
- W4362689449 hasConcept C140944930 @default.
- W4362689449 hasConcept C150194340 @default.
- W4362689449 hasConcept C189235521 @default.
- W4362689449 hasConcept C190727270 @default.
- W4362689449 hasConcept C203014093 @default.
- W4362689449 hasConcept C2776914184 @default.
- W4362689449 hasConcept C33288867 @default.
- W4362689449 hasConcept C502942594 @default.
- W4362689449 hasConcept C54355233 @default.
- W4362689449 hasConcept C86803240 @default.
- W4362689449 hasConceptScore W4362689449C104317684 @default.
- W4362689449 hasConceptScore W4362689449C12823836 @default.
- W4362689449 hasConceptScore W4362689449C13373296 @default.
- W4362689449 hasConceptScore W4362689449C140944930 @default.
- W4362689449 hasConceptScore W4362689449C150194340 @default.
- W4362689449 hasConceptScore W4362689449C189235521 @default.
- W4362689449 hasConceptScore W4362689449C190727270 @default.
- W4362689449 hasConceptScore W4362689449C203014093 @default.
- W4362689449 hasConceptScore W4362689449C2776914184 @default.
- W4362689449 hasConceptScore W4362689449C33288867 @default.
- W4362689449 hasConceptScore W4362689449C502942594 @default.
- W4362689449 hasConceptScore W4362689449C54355233 @default.
- W4362689449 hasConceptScore W4362689449C86803240 @default.
- W4362689449 hasIssue "174" @default.
- W4362689449 hasLocation W43626894491 @default.
- W4362689449 hasLocation W43626894492 @default.
- W4362689449 hasOpenAccess W4362689449 @default.
- W4362689449 hasPrimaryLocation W43626894491 @default.
- W4362689449 hasRelatedWork W1178848704 @default.
- W4362689449 hasRelatedWork W1519915707 @default.
- W4362689449 hasRelatedWork W1970892827 @default.
- W4362689449 hasRelatedWork W1992106366 @default.
- W4362689449 hasRelatedWork W2033244804 @default.
- W4362689449 hasRelatedWork W2054284274 @default.
- W4362689449 hasRelatedWork W2417345120 @default.
- W4362689449 hasRelatedWork W2609822003 @default.
- W4362689449 hasRelatedWork W2775607012 @default.
- W4362689449 hasRelatedWork W2911544435 @default.
- W4362689449 hasVolume "35" @default.
- W4362689449 isParatext "false" @default.
- W4362689449 isRetracted "false" @default.
- W4362689449 workType "article" @default.